CF PharmTech Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	8,044	14,417	-	-	-	-
Enterprise Value	7,476	14,168	-	-	-	-
Last Close Price	19.57	35.00	-	-	-	-
PE Ratio	2908.80	5213.44	-	-	-	-
PS Ratio	16.71	29.95	-	-	-	-
PB Ratio	4.92	8.82	-	-	-	-
P/TBV Ratio	5.50	9.86	-	-	-	-
EV/Sales Ratio	15.53	29.44	-	-	-	-
EV/EBITDA Ratio	201.27	379.52	-	-	-	-
Debt / Equity Ratio	0.10	0.10	0.08	0.02	0.00	0.00
Debt / EBITDA Ratio	4.34	4.34	1.27	0.40	-	-
Debt / FCF Ratio	-	-	-	13.26	-	-
Net Debt / Equity Ratio	-0.35	-0.35	-0.29	-0.42	-0.37	-0.43
Net Debt / EBITDA Ratio	-15.22	-15.22	-4.80	-7.62	6.12	2.00
Net Debt / FCF Ratio	-	-	3.86	-232.94	6.90	1.55
Asset Turnover	0.28	0.28	0.51	0.52	0.35	0.04
Inventory Turnover	2.49	2.49	2.83	3.16	3.47	1.84
Quick Ratio	4.23	4.23	1.56	2.40	2.37	5.24
Current Ratio	4.59	4.59	1.88	2.89	3.53	6.25
Return on Equity (ROE)	0.21%	0.21%	2.28%	3.58%	-5.62%	-13.82%
Return on Assets (ROA)	-0.83%	-0.83%	0.19%	0.13%	-5.34%	-13.19%
Return on Capital Employed (ROCE)	-1.30%	-1.30%	0.40%	0.20%	-9.80%	-23.70%
Earnings Yield	0.03%	0.02%	-	-	-	-
Buyback Yield / Dilution	-1.85%	-1.85%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.